Global Kidney Cancer Drugs Market Size, Status and Forecast 2022

2017-10-09 / 3300.00 / Service / 101 Pages

Description

This report studies the global Kidney Cancer Drugs market, analyzes and researches the Kidney Cancer Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Pfizer
Abbott Laboratories
Glaxosmithkline PLC
Novartis AG
Bayer AG
Active Biotech
Amgen
Cipla Limited
F. Hoffmann-La Roche
Genentech
Prometheus Laboratories
Exelixis
Onyx Pharmaceuticals
Aveo Pharmaceuticals
Immatics Biotechnologies

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Kidney Cancer Drugs can be split into
Nexavar (Sorafenib)
Sutent (Sunitinib)
Afinitor (Everolimus)
Votrient (Pazopanib)
Avastin (Bevacizumab)
Inlyta (Axitinib)
Torisel (Temsirolimus)
Proleukin (Aldesleukin)
Other

Market segment by Application, Kidney Cancer Drugs can be split into
Hospitals
Clinics
Research Center
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Content

Table of Contents

Global Kidney Cancer Drugs Market Size, Status and Forecast 2022
1 Industry Overview of Kidney Cancer Drugs
1.1 Kidney Cancer Drugs Market Overview
1.1.1 Kidney Cancer Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Kidney Cancer Drugs Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Kidney Cancer Drugs Market by Type
1.3.1 Nexavar (Sorafenib)
1.3.2 Sutent (Sunitinib)
1.3.3 Afinitor (Everolimus)
1.3.4 Votrient (Pazopanib)
1.3.5 Avastin (Bevacizumab)
1.3.6 Inlyta (Axitinib)
1.3.7 Torisel (Temsirolimus)
1.3.8 Proleukin (Aldesleukin)
1.3.9 Other
1.4 Kidney Cancer Drugs Market by End Users/Application
1.4.1 Hospitals
1.4.2 Clinics
1.4.3 Research Center
1.4.4 Other

2 Global Kidney Cancer Drugs Competition Analysis by Players
2.1 Kidney Cancer Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Pfizer
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Kidney Cancer Drugs Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Abbott Laboratories
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Kidney Cancer Drugs Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Glaxosmithkline PLC
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Kidney Cancer Drugs Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Novartis AG
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Kidney Cancer Drugs Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Bayer AG
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Kidney Cancer Drugs Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Active Biotech
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Kidney Cancer Drugs Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Amgen
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Kidney Cancer Drugs Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Cipla Limited
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Kidney Cancer Drugs Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 F. Hoffmann-La Roche
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Kidney Cancer Drugs Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Genentech
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Kidney Cancer Drugs Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Prometheus Laboratories
3.12 Exelixis
3.13 Onyx Pharmaceuticals
3.14 Aveo Pharmaceuticals
3.15 Immatics Biotechnologies

4 Global Kidney Cancer Drugs Market Size by Type and Application (2012-2017)
4.1 Global Kidney Cancer Drugs Market Size by Type (2012-2017)
4.2 Global Kidney Cancer Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Kidney Cancer Drugs in Future
4.4 Top Consumer/End Users of Kidney Cancer Drugs

5 United States Kidney Cancer Drugs Development Status and Outlook
5.1 United States Kidney Cancer Drugs Market Size (2012-2017)
5.2 United States Kidney Cancer Drugs Market Size and Market Share by Players (2016 and 2017)

6 EU Kidney Cancer Drugs Development Status and Outlook
6.1 EU Kidney Cancer Drugs Market Size (2012-2017)
6.2 EU Kidney Cancer Drugs Market Size and Market Share by Players (2016 and 2017)

7 Japan Kidney Cancer Drugs Development Status and Outlook
7.1 Japan Kidney Cancer Drugs Market Size (2012-2017)
7.2 Japan Kidney Cancer Drugs Market Size and Market Share by Players (2016 and 2017)

8 China Kidney Cancer Drugs Development Status and Outlook
8.1 China Kidney Cancer Drugs Market Size (2012-2017)
8.2 China Kidney Cancer Drugs Market Size and Market Share by Players (2016 and 2017)

9 India Kidney Cancer Drugs Development Status and Outlook
9.1 India Kidney Cancer Drugs Market Size (2012-2017)
9.2 India Kidney Cancer Drugs Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Kidney Cancer Drugs Development Status and Outlook
10.1 Southeast Asia Kidney Cancer Drugs Market Size (2012-2017)
10.2 Southeast Asia Kidney Cancer Drugs Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Kidney Cancer Drugs Market Size (Value) by Regions (2017-2022)
11.1.1 United States Kidney Cancer Drugs Revenue and Growth Rate (2017-2022)
11.1.2 EU Kidney Cancer Drugs Revenue and Growth Rate (2017-2022)
11.1.3 Japan Kidney Cancer Drugs Revenue and Growth Rate (2017-2022)
11.1.4 China Kidney Cancer Drugs Revenue and Growth Rate (2017-2022)
11.1.5 India Kidney Cancer Drugs Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Kidney Cancer Drugs Revenue and Growth Rate (2017-2022)
11.2 Global Kidney Cancer Drugs Market Size (Value) by Type (2017-2022)
11.3 Global Kidney Cancer Drugs Market Size by Application (2017-2022)

12 Kidney Cancer Drugs Market Dynamics
12.1 Kidney Cancer Drugs Market Opportunities
12.2 Kidney Cancer Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Kidney Cancer Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Kidney Cancer Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source


Table of Figures

List of Tables and Figures

Figure Kidney Cancer Drugs Product Scope
Figure Global Kidney Cancer Drugs Market Size (Million USD) (2012-2017)
Table Global Kidney Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Kidney Cancer Drugs Market Share by Regions in 2016
Figure United States Kidney Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Kidney Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Kidney Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Kidney Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Kidney Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Kidney Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Kidney Cancer Drugs Market Share by Type in 2016
Figure Nexavar (Sorafenib) Market Size (Million USD) and Growth Rate (2012-2017)
Figure Sutent (Sunitinib) Market Size (Million USD) and Growth Rate (2012-2017)
Figure Afinitor (Everolimus) Market Size (Million USD) and Growth Rate (2012-2017)
Figure Votrient (Pazopanib) Market Size (Million USD) and Growth Rate (2012-2017)
Figure Avastin (Bevacizumab) Market Size (Million USD) and Growth Rate (2012-2017)
Figure Inlyta (Axitinib) Market Size (Million USD) and Growth Rate (2012-2017)
Figure Torisel (Temsirolimus) Market Size (Million USD) and Growth Rate (2012-2017)
Figure Proleukin (Aldesleukin) Market Size (Million USD) and Growth Rate (2012-2017)
Figure Other Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Kidney Cancer Drugs Market Share by Application in 2016
Table Key Downstream Customer in Hospitals
Figure Kidney Cancer Drugs Market Size (Million USD) and Growth Rate in Hospitals (2012-2017)
Table Key Downstream Customer in Clinics
Figure Kidney Cancer Drugs Market Size (Million USD) and Growth Rate in Clinics (2012-2017)
Table Key Downstream Customer in Research Center
Figure Kidney Cancer Drugs Market Size (Million USD) and Growth Rate in Research Center (2012-2017)
Table Key Downstream Customer in Other
Figure Kidney Cancer Drugs Market Size (Million USD) and Growth Rate in Other (2012-2017)
Table Kidney Cancer Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure Kidney Cancer Drugs Market Size Share by Players in 2016
Figure Kidney Cancer Drugs Market Size Share by Players in 2017
Table Pfizer Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Pfizer (2012-2017)
Figure Pfizer Kidney Cancer Drugs Business Revenue Market Share in 2016
Table Abbott Laboratories Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Abbott Laboratories (2012-2017)
Figure Abbott Laboratories Kidney Cancer Drugs Business Revenue Market Share in 2016
Table Glaxosmithkline PLC Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Glaxosmithkline PLC (2012-2017)
Figure Glaxosmithkline PLC Kidney Cancer Drugs Business Revenue Market Share in 2016
Table Novartis AG Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Novartis AG (2012-2017)
Figure Novartis AG Kidney Cancer Drugs Business Revenue Market Share in 2016
Table Bayer AG Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Bayer AG (2012-2017)
Figure Bayer AG Kidney Cancer Drugs Business Revenue Market Share in 2016
Table Active Biotech Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Active Biotech (2012-2017)
Figure Active Biotech Kidney Cancer Drugs Business Revenue Market Share in 2016
Table Amgen Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Amgen (2012-2017)
Figure Amgen Kidney Cancer Drugs Business Revenue Market Share in 2016
Table Cipla Limited Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Cipla Limited (2012-2017)
Figure Cipla Limited Kidney Cancer Drugs Business Revenue Market Share in 2016
Table F. Hoffmann-La Roche Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of F. Hoffmann-La Roche (2012-2017)
Figure F. Hoffmann-La Roche Kidney Cancer Drugs Business Revenue Market Share in 2016
Table Genentech Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Genentech (2012-2017)
Figure Genentech Kidney Cancer Drugs Business Revenue Market Share in 2016
Table Prometheus Laboratories Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Prometheus Laboratories (2012-2017)
Figure Prometheus Laboratories Kidney Cancer Drugs Business Revenue Market Share in 2016
Table Exelixis Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Exelixis (2012-2017)
Figure Exelixis Kidney Cancer Drugs Business Revenue Market Share in 2016
Table Onyx Pharmaceuticals Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Onyx Pharmaceuticals (2012-2017)
Figure Onyx Pharmaceuticals Kidney Cancer Drugs Business Revenue Market Share in 2016
Table Aveo Pharmaceuticals Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Aveo Pharmaceuticals (2012-2017)
Figure Aveo Pharmaceuticals Kidney Cancer Drugs Business Revenue Market Share in 2016
Table Immatics Biotechnologies Basic Information List
Table Kidney Cancer Drugs Business Revenue (Million USD) of Immatics Biotechnologies (2012-2017)
Figure Immatics Biotechnologies Kidney Cancer Drugs Business Revenue Market Share in 2016
Table Global Kidney Cancer Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global Kidney Cancer Drugs Market Size Share by Type in 2012
Figure Global Kidney Cancer Drugs Market Size Share by Type in 2013
Figure Global Kidney Cancer Drugs Market Size Share by Type in 2014
Figure Global Kidney Cancer Drugs Market Size Share by Type in 2015
Figure Global Kidney Cancer Drugs Market Size Share by Type in 2016
Figure Global Kidney Cancer Drugs Market Size Share by Type in 2017
Table Global Kidney Cancer Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global Kidney Cancer Drugs Market Size (Million USD) by Application in 2012
Figure Global Kidney Cancer Drugs Market Size (Million USD) by Application in 2013
Figure Global Kidney Cancer Drugs Market Size (Million USD) by Application in 2014
Figure Global Kidney Cancer Drugs Market Size (Million USD) by Application in 2015
Figure Global Kidney Cancer Drugs Market Size (Million USD) by Application in 2016
Figure Global Kidney Cancer Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Kidney Cancer Drugs
Figure United States Kidney Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Kidney Cancer Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States Kidney Cancer Drugs Market Size Share by Players in 2016
Figure United States Kidney Cancer Drugs Market Size Share by Players in 2017
Figure EU Kidney Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Kidney Cancer Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU Kidney Cancer Drugs Market Size Share by Players in 2016
Figure EU Kidney Cancer Drugs Market Size Share by Players in 2017
Figure Japan Kidney Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Kidney Cancer Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan Kidney Cancer Drugs Market Size Share by Players in 2016
Figure Japan Kidney Cancer Drugs Market Size Share by Players in 2017
Figure China Kidney Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Kidney Cancer Drugs Market Size (Million USD) by Players (2012-2017)
Figure China Kidney Cancer Drugs Market Size Share by Players in 2016
Figure China Kidney Cancer Drugs Market Size Share by Players in 2017
Figure India Kidney Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Kidney Cancer Drugs Market Size (Million USD) by Players (2012-2017)
Figure India Kidney Cancer Drugs Market Size Share by Players in 2016
Figure India Kidney Cancer Drugs Market Size Share by Players in 2017
Figure Southeast Asia Kidney Cancer Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Kidney Cancer Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Kidney Cancer Drugs Market Size Share by Players in 2016
Figure Southeast Asia Kidney Cancer Drugs Market Size Share by Players in 2017
Figure Global Kidney Cancer Drugs Market Size (Million USD) by Regions (2017-2022)
Table Global Kidney Cancer Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global Kidney Cancer Drugs Market Size Share by Regions in 2017
Figure Global Kidney Cancer Drugs Market Size Share by Regions in 2022
Figure United States Kidney Cancer Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Kidney Cancer Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Kidney Cancer Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Kidney Cancer Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Kidney Cancer Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Kidney Cancer Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Kidney Cancer Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global Kidney Cancer Drugs Market Size Share by Type in 2017
Figure Global Kidney Cancer Drugs Market Size Share by Type in 2022
Table Global Kidney Cancer Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global Kidney Cancer Drugs Market Size (Million USD) by Application in 2017
Figure Global Kidney Cancer Drugs Market Size (Million USD) by Application in 2022

Request Sample

captcha
Can't read the image? click here to refresh
* mark fields are compulsory